HALEON PLC
LSE:HLN

Watchlist Manager
HALEON PLC Logo
HALEON PLC
LSE:HLN
Watchlist
Price: 380.3 GBX 2.12% Market Closed
Market Cap: 34.4B GBX
Have any thoughts about
HALEON PLC?
Write Note

Intrinsic Value

The intrinsic value of one HLN stock under the Base Case scenario is 336.95 GBX. Compared to the current market price of 380.3 GBX, HALEON PLC is Overvalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HLN Intrinsic Value
336.95 GBX
Overvaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
HALEON PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HLN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HLN?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
HALEON PLC

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about HALEON PLC

Provide an overview of the primary business activities
of HALEON PLC.

What unique competitive advantages
does HALEON PLC hold over its rivals?

What risks and challenges
does HALEON PLC face in the near future?

Has there been any significant insider trading activity
in HALEON PLC recently?

Summarize the latest earnings call
of HALEON PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for HALEON PLC.

Provide P/S
for HALEON PLC.

Provide P/E
for HALEON PLC.

Provide P/OCF
for HALEON PLC.

Provide P/FCFE
for HALEON PLC.

Provide P/B
for HALEON PLC.

Provide EV/S
for HALEON PLC.

Provide EV/GP
for HALEON PLC.

Provide EV/EBITDA
for HALEON PLC.

Provide EV/EBIT
for HALEON PLC.

Provide EV/OCF
for HALEON PLC.

Provide EV/FCFF
for HALEON PLC.

Provide EV/IC
for HALEON PLC.

Show me price targets
for HALEON PLC made by professional analysts.

What are the Revenue projections
for HALEON PLC?

How accurate were the past Revenue estimates
for HALEON PLC?

What are the Net Income projections
for HALEON PLC?

How accurate were the past Net Income estimates
for HALEON PLC?

What are the EPS projections
for HALEON PLC?

How accurate were the past EPS estimates
for HALEON PLC?

What are the EBIT projections
for HALEON PLC?

How accurate were the past EBIT estimates
for HALEON PLC?

Compare the revenue forecasts
for HALEON PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of HALEON PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of HALEON PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of HALEON PLC compared to its peers.

Compare the P/E ratios
of HALEON PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing HALEON PLC with its peers.

Analyze the financial leverage
of HALEON PLC compared to its main competitors.

Show all profitability ratios
for HALEON PLC.

Provide ROE
for HALEON PLC.

Provide ROA
for HALEON PLC.

Provide ROIC
for HALEON PLC.

Provide ROCE
for HALEON PLC.

Provide Gross Margin
for HALEON PLC.

Provide Operating Margin
for HALEON PLC.

Provide Net Margin
for HALEON PLC.

Provide FCF Margin
for HALEON PLC.

Show all solvency ratios
for HALEON PLC.

Provide D/E Ratio
for HALEON PLC.

Provide D/A Ratio
for HALEON PLC.

Provide Interest Coverage Ratio
for HALEON PLC.

Provide Altman Z-Score Ratio
for HALEON PLC.

Provide Quick Ratio
for HALEON PLC.

Provide Current Ratio
for HALEON PLC.

Provide Cash Ratio
for HALEON PLC.

What is the historical Revenue growth
over the last 5 years for HALEON PLC?

What is the historical Net Income growth
over the last 5 years for HALEON PLC?

What is the current Free Cash Flow
of HALEON PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for HALEON PLC.

Business Breakdown

Haleon PLC emerged as a significant player in the global consumer health market when it was spun off from GlaxoSmithKline in July 2022. As a standalone entity, Haleon focuses on delivering everyday health products that enhance personal well-being, relying on a portfolio brimming with trusted brands like Sensodyne, Panadol, and Voltaren. With an impressive presence in over 100 countries, the company capitalizes on the growing consumer shift towards preventative healthcare and wellness, offering a range of over-the-counter medications, oral health products, and vitamins. This strategic approach positions Haleon not only as a trusted name but also as a vital contributor to the ongoing trend of...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
HALEON PLC

Current Assets 4.7B
Cash & Short-Term Investments 531m
Receivables 2.2B
Other Current Assets 2B
Non-Current Assets 28.7B
Long-Term Investments 81m
PP&E 1.9B
Intangibles 26.4B
Other Non-Current Assets 377m
Current Liabilities 5.6B
Accounts Payable 3.6B
Short-Term Debt 48m
Other Current Liabilities 2B
Non-Current Liabilities 11.2B
Long-Term Debt 7.4B
Other Non-Current Liabilities 3.8B
Efficiency

Earnings Waterfall
HALEON PLC

Revenue
11.2B GBP
Cost of Revenue
-4.3B GBP
Gross Profit
7B GBP
Operating Expenses
-4.8B GBP
Operating Income
2.1B GBP
Other Expenses
-919m GBP
Net Income
1.2B GBP

Free Cash Flow Analysis
HALEON PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

The company reported robust first-half results with significant improvements in gross margin and organic sales growth. Confidence remains high in the full-year guidance of 4-6% organic revenue growth, translating to 5-9% in H2. Higher A&P spending is anticipated to support brand investments and the Eroxon launch. The medium-term objective is reducing net debt to 2.5x EBITDA by year-end, bolstered by strong cash flows and strategic divestments. Despite easing inflation, the cost impact will persist but be partly offset by operational efficiencies. Overall, the portfolio is performing well, with notable strength in Centrum and Oral Care brands.

What is Earnings Call?
Fundamental Scores

HLN Profitability Score
Profitability Due Diligence

HALEON PLC's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Revenue Growth Forecast
54/100
Profitability
Score

HALEON PLC's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

HLN Solvency Score
Solvency Due Diligence

HALEON PLC's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
43/100
Solvency
Score

HALEON PLC's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HLN Price Targets Summary
HALEON PLC

Wall Street analysts forecast HLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HLN is 406.16 GBX with a low forecast of 343.4 GBX and a high forecast of 478.8 GBX.

Lowest
Price Target
343.4 GBX
10% Downside
Average
Price Target
406.16 GBX
7% Upside
Highest
Price Target
478.8 GBX
26% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HLN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for HLN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

HLN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

HLN News

Other Videos

Profile

HALEON PLC Logo
HALEON PLC

Country

United Kingdom

Industry

Consumer products

Market Cap

34.7B GBP

Dividend Yield

1.63%

Description

HALEON PLC is a GB-based company operating in Personal Products industry. The company is headquartered in Brentford, Middlesex and currently employs 22,800 full-time employees. The company went IPO on 2022-07-18. Haleon plc is a consumer healthcare company. The firm's product portfolio is divided among five categories: Oral Health; Pain Relief; vitamins, minerals and supplements (VMS); Respiratory Health; Digestive Health, and Other. Its portfolio of brands includes Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax and Centrum. In addition, the Company also has local strategic brands, which include TUMS, ENO, Flonase, ChapStick, Emergen-C, Fenbid, Grand-Pa, and Dr.BEST. The firm operates its business units in three regions: North America; Europe, Middle East, and Africa (EMEA) and Latin America (LatAm), and Asia-Pacific (APAC).

Contact

MIDDLESEX
Brentford
Building 5, First Floor, The Heights
+441932822000

IPO

2022-07-18

Employees

22 800

Officers

CEO & Executive Director
Mr. Brian James McNamara
CFO & Executive Director
Mr. Tobias Hannes Hestler
Chief Digital & Technology Officer
Ms. Claire Dickson
Head of Investor Relations
Ms. Sonya Ghobrial
General Counsel
Mr. Adrian Charles Morris
Chief Marketing Officer
Ms. Tamara Rogers
Show More
Chief Human Resources Officer
Ms. Line De Decker
President of EMEA & LatAm
Mr. Filippo Lanzi
President of Asia Pacific
Mr. Keith Choy
President of North America
Ms. Lisa Paley
Show Less

See Also

Discover More
What is the Intrinsic Value of one HLN stock?

The intrinsic value of one HLN stock under the Base Case scenario is 336.95 GBX.

Is HLN stock undervalued or overvalued?

Compared to the current market price of 380.3 GBX, HALEON PLC is Overvalued by 11%.

Back to Top